DFX Intelligence
Sosv Indiebio Genesis Consortium II LP
As of · the latest observation of this vehicle; each figure below carries its own filing date
Active deploymentFundraising status unknownADV: Venture Capital Fund
As of · the latest observation of this vehicle; each figure below carries its own filing date
What matters now
- -49%reported GAV
Reported gross assets fell from $8.9M to $4.54M between the Form ADV filings of 18 Mar 2024 and 23 Mar 2026.
The fund's assets as the adviser swears them, never its size or dry powder.
Drawing the relationship network…
Amounts, each with its basis
- Vintage
- 2023basis: adv first reported
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- indefinitewhat may be sold, not what was raised; file 021-471506, sworn by the adviser or filed under this vehicle
- Form D sold
- $0as of the filing of Jan 23, 2023
- First sale
- unknown
- Reported GAV
- $4.5Mon the Form ADV filed Mar 23, 2026; the fund's assets, never its size or dry powder
- Owners (ADV)
- 78
- Reported on ADV
- Mar 16, 2023 to Mar 23, 2026
Fundraising evidence
What counts as raisingA Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.Unknown
latest Form D 2023-01-23, older than 15 months (fr-1)
evidence dated Jan 23, 2023.
Lifecycle
Active deployment
Lifecycle
vintage 2 to 4 years
age years: 3first sale: n/avintage year: 2023adv gav as of: Mar 23, 2026vintage basis: ADV first reportedform d sold: $0form d offering: n/aform d latest filed at: Jan 23, 2023
The fund's own reporting through time
3 Form ADV filings
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| Mar 16, 2023 | Venture Capital Fund | $7.5M | 76 | $500,000 | 47% | no | |
| Mar 18, 2024 | Venture Capital Fund | $8.9M | 78 | $500,000 | 37% | no | |
| Mar 23, 2026 | Venture Capital Fund | $4.5M | 78 | $500,000 | 37% |
Principals and agents
2 principals on Form D, 0 placement agents
- General Partner Sosv Investments, LLC Promoter
- Sean O'Sullivan Promoter
Service providers
none named
No auditor, administrator, custodian or placement agent is named for this vehicle on a filing DFX holds.
Limited partners and their reported performance
Whose numbers these areEach row is the LP’s own number: its cash flows and its valuation policy as of its reporting date, not the fund’s. Net IRR is printed only when the LP prints one. The vintage is the LP’s definition (CalPERS: year of its first cash flow; WSIB: year of its initial investment).0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Known LPs and allocators
What these amounts and dates areA commitment date prints only when the source printed one; otherwise the row carries the date of the report that listed it. A foundation’s 990-PF line is a holding at fair value on its return, never a commitment.0 relationships, public pensions and the allocator graph, each counted once
No allocator names this vehicle in a public disclosure DFX holds: pension reports, foundation 990-PF returns or endowment disclosures.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
2 events
- Mar 16, 2023Sosv Indiebio Genesis Consortium II LP first reported on Form ADV by Sosv Investments LLC (f/k/a Sosventures LLC) (Venture Capital Fund), GAV $7,500,000Fund first reported on Form ADV Fact Form ADV
- Jan 23, 2023Sosv Indiebio Genesis Consortium II, L.P. filed Form D: no sales yet (indefinite offering), Venture Capital FundForm D filed Fact Form D
Evidence
15 observations
Every observation on this vehicle
- Entity type: Limited Partnership Jan 23, 2023 Fact Form D
- Form D fund type: Venture Capital Fund Jan 23, 2023 Fact Form D
- Form D industry group: Pooled Investment Fund Jan 23, 2023 Fact Form D
- Amendment: false Jan 23, 2023 Fact Form D
- Revenue range (Form D): Decline to Disclose Jan 23, 2023 Fact Form D
- Incorporated: withinFiveYears Jan 23, 2023 Fact Form D
- Jurisdiction: Delaware Jan 23, 2023 Fact Form D
- Amount sold (Form D): $0 Jan 23, 2023 Fact Form D
- Exemptions: 06b, 3C, 3C.1, 3C.7 Jan 23, 2023 Fact Form D
- Indefinite offering: true Jan 23, 2023 Fact Form D
- Investors (Form D): 0 Jan 23, 2023 Fact Form D
- Minimum investment (Form D): 0 Jan 23, 2023 Fact Form D
- Securities offered: pooled Jan 23, 2023 Fact Form D
- Office address: Jan 23, 2023 Fact Form D
- Year of incorporation: 2022 Jan 23, 2023 Fact Form D
Relationships across DFX
on 1 other DFX graph
Across the graphs
Sosv Indiebio Genesis Consortium II LP is the same institution as 1 record in RIA and Wealth.
RIA and Wealth1
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…
Record history
2 dated events on the change ledger, latest event first
- Fund first reported on ADV2023-03-16source on record
- Form D filed2023-01-23source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.